A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...

Aurobindo Pharma shares fell 4.67 per cent to hit a high of Rs 1,039.30 on BSE, commanding a market capitalisation of just ...

Reports suggested it has emerged as the frontrunner to acquire Prague-based Zentiva for $5 to $5.5 billion. If completed, this would be the largest-ever acquisition by an Indian pharma company.

Aurobindo Pharma shares fell nearly 5% to ₹1,039 amid reports it may acquire Zentiva for $5-5.5 billion. This would be the ...

If completed, the deal would mark the largest-ever acquisition by an Indian pharmaceutical company, surpassing Biocon ...

Olutasidenib could dramatically extend survival and reduce dependence on transfusions for certain patients with myelodysplastic syndrome, according to results of a phase 1/2 investigation.Individuals ...

Opportunistically placed pop-up screening stations may help improve detection and awareness of cardiovascular risk factors ...

Aurobindo Pharma said it 'regularly explores' various strategic opportunities, including potential acquisitions and partnerships, which can enhance shareholder value.

DelveInsight's FGFR Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The FGFR inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of conditions such as urothelial carcinoma, cholangiocarcinoma, and ...

Merck announced a significant regulatory milestone with a Breakthrough Therapy designation for its lung cancer drug. This FDA ...